Degu Insulin provides some control of postprandial blood glucose. Degu Insulin is a basal insulin that produces the same pharmacodynamic effect (i.e., lowering blood glucose) as human insulin and is suitable for the treatment of diabetes mellitus. Contraindication to the use of the drug is hypersensitivity to Degu Insulin or any of the excipients in the product. The drug is primarily used as a long-acting basal insulin to control the patient’s blood glucose levels throughout the day. Of course, short-acting insulin is also available for postprandial glucose control. The most common adverse reaction during treatment is hypoglycemia, in addition to injection site reactions, fat metabolism disorders, urticaria, hypersensitivity reactions and other adverse reactions can occur. Note that blood glucose should be monitored during use. Specific medications should be administered under the guidance of a specialist.